Clinical Trial Update: Gemcitabine/Cisplatin Versus Gemcitabine/Epirubicin for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing gemcitabine/cisplatin versus gemcitabine/epirubicin in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Epirubicin (epirubicin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: COMPLETED